Ars Pharmaceuticals Inc (SPRY)

$OPEN Anyone who currently uses a EpiPen Neffy $SPRY is about to start eating $TEVA lunch! Needle-free Neffy now approved in U.S., EU & UK, with Canada/Japan up next… pediatric expansion + long shelf life = global adoption 🚀 Hot cakes incoming. $SPRY – Global Growth Story Approved: • U.S.: Both doses (2 mg ≥66 lb & 1 mg 33–66 lb) approved – full market coverage. • EU: 2 mg (≥66 lb) approved Aug 2024. • U.K.: 2 mg (≥66 lb) approved Jul 2025. Pending / Estimated Approvals: • U.K./EU Pediatric 1 mg (33–66 lb): Under review – expected 2026. • Canada & Japan: Filings in progress – decisions late 2025. • China & Australia: Filings submitted – decisions expected 2026. Bullish Drivers: • Needle-free and easy to use – preferred by parents, schools, and institutions. • Longer shelf life (~30 months) – reduces costs, boosts adoption. • Insurance + school programs expanding in U.S. → model for global rollout. • Pediatric approval unlocks millions of new patients (U.S. now, EU/UK likely 2026). • Licensing deals + strong cash runway = no immediate dilution risk. Bottom line: SPRY is turning Neffy into the global standard for anaphylaxis rescue. With each approval adding new patients and geographies, revenue growth could accelerate sharply — making a stock double very realistic.

$SPRY damn, on green day like today, some Tutes are def dumping hard...

$SPRY 😎 TTP

$SPRY The OI Put/Call Ratio for SPRY / ARS Pharmaceuticals, Inc. is 0.42. The Put/Call Ratio shows the total number of disclosed open put option positions divided by the number of open call options. Since puts are generally a bearish bet and calls are a bullish bet, put/call ratios greater than 1 indicate a bearish sentiment, and ratios less than one indicate a bullish sentiment.

$SPRY according to YF insiders own 17% and institutions own 86%. The total even without retail is over 100%!!!! Is there a naked shorting of involved?

$SPRY 10-Qs matter, but they don’t tell the whole story. Institutions have been steadily accumulating, SPRY is oversold, and catalysts ahead make the setup attractive. The market prices future potential, not just current numbers

$SPRY glta imma keep buying and be ready

$SPRY @Eskouvion B.O. before December

$SPRY $SPY $DJI https://stocktwits.com/BostonNorthern/message/626237901